Key result
Transplacental antiarrhythmic therapy achieved complete efficacy, restoring and maintaining sinus rhythm until delivery, in 83.9% of fetuses with life-threatening tachyarrhythmias.
Why the study?
To present the modern state of support for pregnant women with foetal tachyarrhythmias.
Does foetal therapy improve perinatal outcomes in pregnant women with foetal tachyarrhythmias?
Does foetal therapy improve perinatal outcomes in pregnant women with foetal tachyarrhythmias?
Early initiation of foetal therapy for tachyarrhythmias is crucial to improve perinatal outcomes and prevent foetal or neonatal death.
Prompt foetal therapy may improve outcomes in tachyarrhythmias; leaves open confirmation in prospective trials.
Objective of the Review: To present the modern state of the support for pregnant women with foetal tachyarrhythmias. Key Points. The antenatal diagnosis of arrhythmia, pregnancy and labour in women with this foetal pathology are discussed. The causes of arrhythmias and nonimmune foetal dropsy, characteristics of foetal myocardium, have been analysed. The need in the therapy of lifethreatening foetal tachyarrythmias has been justified. Medical assistance to this category of patients has been presented. Conclusion. Foetal tachyarrythmia is a significant cause of increased antenatal and infant mortality rates; if untreated, it leads to the death of the foetus/newborn. When started right after the diagnosis of tachyarrythmia, foetal therapy can significantly improve perinatal outcomes due to foetus stabilisation or complete antenatal recovery; it makes it possible for a woman to deliver a term baby and to minimise the treat of a poor outcome.
No takes yet. Share an insight, caveat, or question.
E.L. Bokeriya (2021) conducted a review in Fetal tachyarrhythmias (n=60). Transplacental antiarrhythmic therapy was evaluated on Complete efficacy (medical cardioversion, restoration and maintenance of sinus rhythm in the fetus until delivery). Transplacental antiarrhythmic therapy achieved complete efficacy, restoring and maintaining sinus rhythm until delivery, in 83.9% of fetuses with life-threatening tachyarrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: